BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAND
2751
Gladstone Land Corp
LAND
$358M
| $43.7M | ﹤0.01% |
1,920,342
+119,382
| +7% | +$2.78M |
|
|
RDUS
2752
DELISTED
Radius Health, Inc.
RDUS
| $43.7M | ﹤0.01% |
3,519,767
-134,954
| -4% | -$1.95M |
|
|
SRG
2753
Seritage Growth Properties
SRG
$128M
| $43.6M | ﹤0.01% |
2,940,216
-118,557
| -4% | -$1.87M |
|
|
GNOG
2754
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $43.6M | ﹤0.01% |
2,507,550
+293,678
| +13% | +$4.92M |
|
2755
GoodRx Holdings
GDRX
$1.27B
| $43.5M | ﹤0.01% |
1,060,859
-139,805
| -12% | -$5.07M |
|
|
GTHX
2756
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $43.5M | ﹤0.01% |
3,242,085
+12,319
| +0.4% | +$201K |
|
2757
Adecoagro
AGRO
$1.31B
| $43.2M | ﹤0.01% |
4,789,013
+395,227
| +9% | +$3.71M |
|
|
ATRS
2758
DELISTED
Antares Pharma, Inc.
ATRS
| $43.2M | ﹤0.01% |
11,875,493
+187,324
| +2% | +$757K |
|
|
KNTE
2759
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $43.1M | ﹤0.01% |
1,874,361
+600,832
| +47% | +$13.1M |
|
|
MRC
2760
DELISTED
MRC Global
MRC
| $42.8M | ﹤0.01% |
5,831,222
-232,635
| -4% | -$1.93M |
|
2761
Acumen Pharmaceuticals
ABOS
$184M
| $42.6M | ﹤0.01% |
+2,868,791
| New | +$47.7M |
|
2762
Legend Biotech
LEGN
$3.93B
| $42.4M | ﹤0.01% |
837,927
+35,330
| +4% | +$1.47M |
|
|
CLVS
2763
DELISTED
Clovis Oncology, Inc.
CLVS
| $42.3M | ﹤0.01% |
9,495,073
+679,399
| +8% | +$3.27M |
|
|
CPRX
2764
DELISTED
Catalyst Pharmaceutical
CPRX
| $42.2M | ﹤0.01% |
7,962,533
-43,304
| -0.5% | -$237K |
|
2765
CALL
Nucor
NUE
$61.8B
| $42.2M | ﹤0.01% |
428,000
-81,700
| -16% | -$8.69M |
|
|
IGMS
2766
DELISTED
IGM Biosciences
IGMS
| $42.1M | ﹤0.01% |
640,737
+7,936
| +1% | +$607K |
|
|
ITOS
2767
DELISTED
iTeos Therapeutics
ITOS
| $42.1M | ﹤0.01% |
1,558,236
+41,498
| +3% | +$1.08M |
|
2768
Cass Information Systems
CASS
$750M
| $42M | ﹤0.01% |
1,003,695
-10,415
| -1% | -$443K |
|
|
AFMD
2769
DELISTED
Affimed
AFMD
| $41.9M | ﹤0.01% |
677,809
+4,415
| +0.7% | +$291K |
|
2770
Standard BioTools
LAB
$294M
| $41.9M | ﹤0.01% |
6,350,729
-13,207
| -0.2% | -$86.9K |
|
|
RYZ
2771
Ryerson Holding Corp
RYZ
$1.5B
| $41.8M | ﹤0.01% |
1,877,774
-80,193
| -4% | -$1.57M |
|
2772
Inseego
INSG
$77.7M
| $41.7M | ﹤0.01% |
626,822
-2,658
| -0.4% | -$222K |
|
2773
Privia Health
PRVA
$2.78B
| $41.7M | ﹤0.01% |
1,770,907
-687,529
| -28% | -$24M |
|
|
AKRO
2774
DELISTED
Akero Therapeutics
AKRO
| $41.7M | ﹤0.01% |
1,866,557
+18,709
| +1% | +$424K |
|
|
BOWX
2775
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
| $41.6M | ﹤0.01% |
4,158,000
| – | – |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.